Meiji Holdings

Meiji Holdings Co., Ltd., through its subsidiaries, manufactures and sells dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, cheese, drinking milk, beverages, butter and margarine, cream, ice cream, ready meals, chocolates, gummy products, chewing gums, sports nutrition products, infant formula, liquid diet, beauty supplements, OTC medicines, feed stuffs, corn sweeteners, and sugar, as well as transportation and distribution services. The company also offers drugs for infectious diseases and central nervous system disorders, as well as generic drugs; agricultural and livestock chemicals; human and animal vaccines, and blood plasma products; and veterinary drugs for livestock and fisheries comprising antimicrobial injection, disinfectants, oral administration, insecticides, anthelmintic, antipyretic, analgesic, anti-inflammatory, hemostatic, and breeding agents. In addition, it provides insecticides, metabolites, feed additives, and mixed feed; and companion animals, including anesthetics and painkillers, anti-parasitic and gastrointestinal drugs, anti-bacterial agents, antiplasmin agents, vitamin E preparations, and dietary supplements. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.

Meiji's mission is to improve the health and wellness of people around the world. We aim to create products and services that promote health and well-being, while also advancing science and technology.

Meiji's vision is to be a trusted leader in the global health and nutrition industry, creating products that benefit and enrich the lives of people around the world.

Meiji has been honored with numerous awards and accolades, including being named the Most Admired Company in Japan, the Japan Quality Medal, and the Minister of Health, Labor, and Welfare Award. In 2018, the company was also recognized by Pharmaceutical Researchers and Manufacturers of America for its commitment to advancing the development and delivery of groundbreaking medicines and treatments.